755 related articles for article (PubMed ID: 8751457)
21. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
[TBL] [Abstract][Full Text] [Related]
22. c-mpl, the thrombopoietin receptor.
Vainchenker W; Methia N; Debili N; Titeux M; Wendling F
Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519
[TBL] [Abstract][Full Text] [Related]
23. Tyrosine-599 of the c-Mpl receptor is required for Shc phosphorylation and the induction of cellular differentiation.
Alexander WS; Maurer AB; Novak U; Harrison-Smith M
EMBO J; 1996 Dec; 15(23):6531-40. PubMed ID: 8978680
[TBL] [Abstract][Full Text] [Related]
24. Phorbol ester PMA induces expression of the thrombopoietin receptor MPL in leukemia cells.
Graf G; Zaborski M; Quentmeier H; Drexler HG
Leuk Lymphoma; 1996 Dec; 24(1-2):149-57. PubMed ID: 9049971
[TBL] [Abstract][Full Text] [Related]
25. Effect of thrombopoietin on proliferation of blasts from patients with myelodysplastic syndromes.
Luo SS; Ogata K; Yokose N; Kato T; Dan K
Stem Cells; 2000; 18(2):112-9. PubMed ID: 10742383
[TBL] [Abstract][Full Text] [Related]
26. Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin.
Matsumura I; Kanakura Y; Kato T; Ikeda H; Ishikawa J; Horikawa Y; Hashimoto K; Moriyama Y; Tsujimura T; Nishiura T
Blood; 1995 Jul; 86(2):703-9. PubMed ID: 7541672
[TBL] [Abstract][Full Text] [Related]
27. Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein.
Hill RJ; Zozulya S; Lu YL; Hollenbach PW; Joyce-Shaikh B; Bogenberger J; Gishizky ML
Cell Growth Differ; 1996 Sep; 7(9):1125-34. PubMed ID: 8877093
[TBL] [Abstract][Full Text] [Related]
28. Thrombopoietin and its receptor.
Wendling F; Vainchenker W
Eur Cytokine Netw; 1998 Sep; 9(3):221-31. PubMed ID: 9831170
[TBL] [Abstract][Full Text] [Related]
29. Thrombopoietin: the primary regulator of megakaryocyte and platelet production.
Kaushansky K
Thromb Haemost; 1995 Jul; 74(1):521-5. PubMed ID: 8578518
[TBL] [Abstract][Full Text] [Related]
30. Tyrosine 462 of the membrane-proximal F'-G' loop of murine Mpl is not essential for high-affinity binding of thrombopoietin.
Sabath DF; Lin N; Sabath DE; Kaushansky K; Broudy VC
Cytokine; 2000 Feb; 12(2):127-33. PubMed ID: 10671297
[TBL] [Abstract][Full Text] [Related]
31. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
[TBL] [Abstract][Full Text] [Related]
32. Circulating thrombopoietin as an in vivo growth factor for blast cells in acute myeloid leukemia.
Corazza F; Hermans C; D'Hondt S; Ferster A; Kentos A; Benoît Y; Sariban E
Blood; 2006 Mar; 107(6):2525-30. PubMed ID: 16317100
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of c-mpl expression in myelodysplastic syndromes.
Bouscary D; Preudhomme C; Ribrag V; Melle J; Viguié F; Picard F; Guesnu M; Fenaux P; Gisselbrecht S; Dreyfus F
Leukemia; 1995 May; 9(5):783-8. PubMed ID: 7539513
[TBL] [Abstract][Full Text] [Related]
34. Tec protein-tyrosine kinase is involved in the thrombopoietin/c-Mpl signaling pathway.
Yamashita Y; Miyazato A; Shimizu R; Komatsu N; Miura Y; Ozawa K; Mano H
Exp Hematol; 1997 Mar; 25(3):211-6. PubMed ID: 9091296
[TBL] [Abstract][Full Text] [Related]
35. [Thrombopoietic growth factor--thrombopoietin. Molecular and biological properties].
Skotnicki AB; Jabłoński MJ
Przegl Lek; 1996; 53(11):826-9. PubMed ID: 9173448
[TBL] [Abstract][Full Text] [Related]
36. Thrombopoietin receptor expression in human cancer cell lines and primary tissues.
Columbyova L; Loda M; Scadden DT
Cancer Res; 1995 Aug; 55(16):3509-12. PubMed ID: 7627956
[TBL] [Abstract][Full Text] [Related]
37. Thrombopoietin: biology and clinical potentials.
Miyazaki H; Kato T
Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
[TBL] [Abstract][Full Text] [Related]
38. Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells.
Dehmel U; Zaborski M; Meierhoff G; Rosnet O; Birnbaum D; Ludwig WD; Quentmeier H; Drexler HG
Leukemia; 1996 Feb; 10(2):261-70. PubMed ID: 8637235
[TBL] [Abstract][Full Text] [Related]
39. [Clinical use of thrombopoietin (c-Mpl Ligand)].
Borota R; Borota J; Belić A; Gebauer E; Stefanović N
Med Pregl; 1998; 51(11-12):501-8. PubMed ID: 10081270
[TBL] [Abstract][Full Text] [Related]
40. Thrombopoietin and the c-Mpl receptor: insights from gene targeting.
Alexander WS
Int J Biochem Cell Biol; 1999 Oct; 31(10):1027-35. PubMed ID: 10582337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
